Towards a proteomic plasma biomarker panel for diagnosing vasculitis remission
Year: 2025
Type: article
Abstract: : Active autoimmune vasculitis requires intensive immunosuppressive therapy, but continued treatment after remission is achieved can cause serious harm. Reliable biomarkers to confirm remission are lacking, forcing clinicians to prolong cost-intensive and toxic therapy unnecessarily. Routine markers, such as C-reactive protein and anti-neutrophil cytoplasmic antibodies, lack sensitivity and specificity for the remission status, failing to guide treatment de-escalation safely. We hypothesized that the plasma proteome, when rigorously controlled for patient characteristics and clinical confounders, contains biomarkers that reliably diagnose remission in autoimmune vasculitis patients. To test this assumption, we applied a two-tiered proteomics strategy combining global discovery with targeted validation to identify a robust protein signature of remission. The resulting 7-protein panel was successfully implemented in a targeted mass spectrometry-based assay, with diagnostic performance confirmed in an independent patient cohort. The panel consistently outperformed routine markers. We propose this panel as a robust clinical tool to support decision-making, with the potential to reduce treatment-related burden, mitigate toxicity, and lower healthcare costs. Moreover, our confounder-controlled proteomics approach provides a scalable blueprint for biomarker discovery in complex inflammatory diseases.
Author: Bartolomaeus, Theda Ulrike Patricia
Institution: Max Delbrück Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7077142979
FWCI:
Cites:
Cited by:
Related to: